Acta Vet. Brno 2012, 81: 409-414
https://doi.org/10.2754/avb201281040409
Effects of parenteral administration of enrofloxacin on electrocardiographic parameters in hospitalized dogs
References
1. HC 1920: An analysis of the time relationship of electrocardiograms. Heart 7: 353-370
2. DM, Boeckh A, Boothe HW, Wilkie S 2001: Tissue concentrations of enrofloxacin and ciprofloxacin in anesthetized dogs following single intravenous administration. Vet Therapeutics 2: 120-128
3. GP, Schneider M, Woehrlé F, Lefebvre HP 2005: Effect of marbofloxacin on cardiovascular variables in healthy isoflurane-anesthetized dogs. Am J Vet Res 66: 2090-2094
<https://doi.org/10.2460/ajvr.2005.66.2090>
4. SG, Wotton PR, Boswood A, Flaherty D 2007: Comparison of the effects of thiopentone and propofol on the electrocardiogram of dogs. Vet Rec 160: 681-686
<https://doi.org/10.1136/vr.160.20.681>
5. RR, Malik M, Antzelevitch C, Sanguinetti M, Roden DM, Priori SG, Ruskin JN, Flanagan MC, Mitchell ES, Haigney MC 2006: Ciprofloxacin-induced torsade de pointes. Int J Cardiol 113: 239-241
6. LS 1920: The duration of systole in the electrocardiogram of normal subjects and of patients with heart disease. Acta Med Scand 53: 469-486
<https://doi.org/10.1111/j.0954-6820.1920.tb18266.x>
7. MJ, Mull CC, Sharieff GQ, Tsarouhas N 2003: Prolonged QT syndrome in children: an uncommon but potentially fatal entity. J Emerg Med 24: 173-179
<https://doi.org/10.1016/S0736-4679(02)00721-7>
8. MS, Parsamehr R 2009: The effects of intravenous ciprofloxacin on the electrocardiogram of healthy dogs. Vet Res Commun 33: 987-990
<https://doi.org/10.1007/s11259-009-9317-1>
9. A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG 2007: Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 153: 891-899
<https://doi.org/10.1016/j.ahj.2007.01.040>
10. H, Yoshii H, Yabu H, Kumada H, Fukuda K, Mitani S, Rousselot JF, Virose H, Uchino T 2004: Evaluation of QT interval prolongation in dogs with heart failure. J Vet Med Sci 66: 1107-1111
<https://doi.org/10.1292/jvms.66.1107>
11. GC, She JH, Jiang H, Li YZ, Yuan BJ 2008: Sixty-day repeated dose toxicity of sinafloxacin in rats and dogs. Food Chem Toxicol 46: 575-580
<https://doi.org/10.1016/j.fct.2007.08.044>
12. AJ 1999: The QT interval and torsade de pointes. Drug Saf 21: 5-10
<https://doi.org/10.2165/00002018-199921001-00002>
13. A, Larson MG, Goldberg RJ, Bengston JR, Levy D 1992: An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol 70: 797-801
<https://doi.org/10.1016/0002-9149(92)90562-D>
14. RR 2002: The significance of QT interval in drug development. Br J Clin Pharmacol 54: 188-202
<https://doi.org/10.1046/j.1365-2125.2002.01627.x>
15. DJ 2000: Drug-induced proarrhythmic effects: assessment of changes in QT interval. Br J Clin Pharmacol 50: 297-302
<https://doi.org/10.1046/j.1365-2125.2000.00274.x>
16. S, Kanno A, Kitayama T, Sekiya K, Nakai K, Haruna M, Mino T, Miyazaki H, Yano K, Yamamoto k 2005: QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals. J Pharmacol Sci 99: 459-471
<https://doi.org/10.1254/jphs.QT-A2>
17. de Water A, Verheyen J, Xhonneux R, Reneman RS 1989: An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. J Pharmacol Methods 22: 207-217
18. J, Della Penna K, Wang H, Karczewski J, Connolly TM, Koblan TS, Bennett PB, Salata JJ 2003: Functional and pharmacological properties of canine ERG potassium channels. Am J Physiol Heart Circ Physiol 284: 256-267
<https://doi.org/10.1152/ajpheart.00220.2002>
